Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 867 of 1,261

  1. US 8461203

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  2. US 8461192

    Method of selectively inhibiting PKCiota

    The United States of America—Department of Veterans Affairs · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  3. US 8461172

    Solid forms and process for preparing

    Corcept Therapeutics Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  4. US 8461187

    Multiple PPI dosage form

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  5. US 8461154

    Methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  6. US 8460653

    Superoxide dismutase variants and methods of use thereof

    The Regents of the University of California · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  7. US 8460713

    Administration of cells and cellular extracts for rejuvenation

    REGENICS AS · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  8. US 8461153

    Benzodiazepinone compounds useful in the treatment of skin conditions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  9. US 8461156

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  10. US 8461155

    Sclerostin and the inhibition of WNT signaling and bone formation

    UNIVERSITY OF CONNECTICUT · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  11. US 8460864

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    PTC THERAPEUTICS, INC. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  12. US 8460675

    Viral chemokine-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  13. US 8460660

    Anti-mesothelin antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  14. US 8460693

    Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent

    ATRIUM MEDICAL CORPORATION · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  15. US 8461339

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  16. US 8460651

    Methods of treating amyotrophic lateral sclerosis (ALS)

    The Regents of the University of California · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  17. US 8461149

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  18. EP 2599478

    Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon

    ACINO AG [DE] · Granted Jun 5, 2013 · Expires May 31, 2033

    granted

  19. US 8454972

    Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  20. US 8455688

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  21. US 8455653

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  22. US 8455665

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  23. US 8455621

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  24. US 8455565

    Disulfide monomers comprising ethylenically unsaturated groups suitable for dental compositions

    The Regents of the University of Colorado · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.